- £828.56m
- £819.08m
- $157.78m
Half-year Financial Report
Brief: Newton Investment Management Holds 4.87% Stake In Biopharma Credit As At Sept 21 - Filing
Holding(s) in Company
Directorate change
QuotedData's In The HotSeat
Notice of Half Year Results
Completion of Lumira Sale
Director/PDMR Shareholding
Director/PDMR Shareholding
Brief: BioPharma Credit Announces Investment Of Up To $45 Mln In Kestra Medical
NEW INVESTMENT IN KESTRA MEDICAL
UPDATE ON ARCHIMED ESPERION ACQUISITION
Brief: BioPharma Credit Announces New Investment Of Up To CHF 75 Million In Idorsia Pharmaceuticals
Brief: Biopharma Credit Enters Loan Agreement With Mineralys For Up To $150 Million
Director/PDMR Shareholding
Notice of AGM
Brief: BioPharma Credit Says Co's Allocation Of Financing Of Esperion Deal Between $78 Million And $120 Million
Statement re ARCHIMED
Holding(s) in Company